Abstract: Obesity continues increasing at epidemic levels worldwide, as does the number of genetic studies that focus on obesity. Body mass index (BMI) is often used to characterize weight phenotypes and obesity status due to its simplicity. Refined measurements of body composition may be needed to understand variations in gene expression. This study explores gene expression when individuals are characterized as overweight based on BMI versus body fat percent. Individuals were recruited to a natural history protocol at the National Institutes of Health. Twelve Caucasian participants with the highest and lowest BMI were included. Whole-body air displacement plethysmography was performed to calculate body fat percent, and BMI was calculated. Fasting whole blood was collected and RNA extracted. Quantitative real time PCR array was used to determine expression of 96 obesity related genes. The PCR array from participants with high BMI compared to low BMI showed dysregulation of four genes: peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A), pro-opiomelanocortin (POMC), growth hormone secretagogue receptor (GHSR), and leptin (LEP), whereas participants with high body fat compared to low body fat showed dysregulation of one gene: PPARGC1A. This research showed differential gene expression and clinical indices depending on method of weight classification.
INTRODUCTION
Obesity rates continue to rise worldwide and negatively impact health [1] . According to the American Heart Association, modifiable risk factors associated with cardiovascular disease include obesity, high blood cholesterol, elevated blood pressure, sedentary lifestyle, smoking, and diabetes [2] . As the epidemic increases, the number of genetic studies focusing on obesity risk, associated cardiovascular and endocrine risk factors are abounding [3] . Body mass index (BMI) is commonly used to quantify anthropometrics and identify individuals at risk due to its simplicity [4] . Current studies that use BMI as a standard for defining weight phenotypes and cardiovascular risk are limited in that body composition (lean muscle mass and fat mass), age, and gender are not taken into consideration [5, 6] . Individuals are considered overweight if they have a BMI 25 regardless of gender or body composition. More accurate weight classification methods, including underwater weighing, computed tomography scans, and whole-body air displacement plethysmography calculate lean and fat mass and differentiates by gender in that greater than 25% body fat is high for males and greater than 30% is high for females [4] . These refined classify-Weight was measured in triplicate then averaged, and height was measured in duplicate then averaged. The average height and weight were used to determine BMI, calculated as weight in kilograms divided by height in meters squared. A trained registered nurse completed whole-body air displacement plethysmography (BOD POD TM ) on all patients, which determines body fat percent. Intra-abdominal height, a measure from the highest abdominal point to the spine in centimeters while the patient is supine, was calculated via ultrasound. Intra-abdominal height is measured without applying pressure to the ultrasound probe [7] . Venous blood samples were collected in PAXgene TM RNA tubes the morning after an overnight fast and frozen at -80º C. Blood was also sent to the Department of Laboratory Medicine to evaluate routine cardiovascular laboratory values including fasting glucose, total cholesterol, triglycerides, high density lipoprotein (HDL), low density lipoprotein (LDL), and serum insulin.
RNA Extraction and Real-Time PCR
PAXgene tubes were thawed overnight after which RNA was extracted according to manufacturer's instruction using a PAXgene TM blood miRNA kit (Qiagen, Franklin Lakes, NJ) and normalized to 300 ng. RNA integrity was verified using RNA Experion StdSens Analysis Kit. Quantitative real-time PCR array (RT 2 Profiler TM PCR Array) was used to determine gene expression in 84 genes related to obesity ( Table 1 ) after cDNA was reverse transcribed using the RT 
Statistical Analysis
Clinical and demographic data were analyzed using SPSS version 15.0 (SPSS Inc., Chicago, Illinois). Data are presented as mean ± standard deviation. Normality of data was assessed and group differences were determined by independent sample t-test for equality of means. A p-value of less than 0.05 was considered statistically significant. Genetic data were analyzed using SABiosciences RT 
RESULTS
When patients were grouped based on BMI there were significant differences between low BMI and high BMI with regard to BMI (p = 0.004), intra-abdominal height (p = 0.009), systolic blood pressure (SBP) (p = 0.017), and HDL (p = 0.010); there were no significant differences between the groups with regard to age, gender, race, body fat percent, diastolic blood pressure (DBP), glucose, cholesterol, triglycerides, LDL, or serum insulin ( Table 2) . When patients were grouped based on body fat percent there were significant differences between low body fat and high body fat with regard to gender (p = 0.021), body fat percent (p < 0.001), total cholesterol (p = 0.003), triglycerides (p = 0.009), LDL (p = 0.007), and serum insulin (p = 0.041); there were no significant differences between the groups with regard to age, race, BMI, intra-abdominal height, SBP, DBP, glucose, or HDL ( Table 2 ). Note that certain individuals with a high BMI did not have high body fat percent and therefore were grouped differently as seen in Fig. (1)(e.g., ID #4, 5, and 10). Likewise individuals with low BMI had high body fat (e.g., ID # 2, 7, and 11). A  ADCYAP1  ADCYAP1R1  ADIPOQ  ADIPOR1  ADIPOR2  ADRA2B  ADRB1  AGRP  APOA4  ATRN  BDNF  BRS3   B  C3  CALCA  CALCR  CARTPT  CCK  CCKAR  CLPS  CNR1  CNTFR  CPD  CPE  CRHR1   C  DRD1  DRD2  GAL  GALR1  GCG  GCGR  GH1  GH2  GHR  GHRL  GHSR  GLP1R   D  GRP  GRPR  HCRT  HCRTR1  HRH1  HTR2C  IAPP  IL1A  IL1B  IL1R1  IL6  IL6R   E  INS  INSR  LEP  LEPR  MC3R  MCHR1  NMB  NMBR  NMU  NMUR1  NPY  NPY1R   F  NR3C1  NTRK2  NTS  NTSR1  OPRK1  OPRM1  POMC  PPARA  PPARG  PPARGC1A  PRLHR  PTPN1   G  PYY  RAMP3  SIGMAR1  SORT1  SST  SSTR2  THRB  TNF  TRH  UCN  UCP1  ZFP91   H  B2M  HPRT1  RPL13A  GAPDH The PCR array from patient samples with high BMI compared to low BMI showed dysregulation in four of the 84 genes: peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PPARGC1A, 2.71-fold, p = 0.103), proopiomelanocortin (POMC, -3.30-fold, p = 0.316), growth hormone secretagogue receptor (GHSR, -2.40-fold, p = 0.056), and leptin (LEP, -2.51-fold, p = 0.135) (Fig. 2) . The PCR array from patient samples with high body fat compared to low body fat showed dysregulation in only one gene: PPARGC1A (-2.10-fold, p = 0.650) (Fig. 2) .
DISCUSSION
The findings included significant differences in four genes (PPARGC1A, POMC, GHSR, and LEP) when altering the weight phenotype classification method [9] [10] [11] [12] [13] [14] [15] . Due to the simplicity and convenience of BMI, seeing similar gene expression patterns regardless of BMI or body fat classification would be ideal. However, the aforementioned results are contradictory with variations in both gene expression and clinical indices related to grouping based on BMI verses body fat percent. Differences in gene expression were found when grouping individuals based on BMI and body fat. Individuals grouped by a high body fat when compared to controls (low body fat) showed dysregulation in one gene (PPARGCIA). Whereas, grouping individuals based on high BMI when compared to controls (low BMI) showed dysregulation in four genes (PPARGC1A, POMC, GHSR, LEP). Specifically, an absence of leptin has been shown to activate the POMC signaling cascade which leads to decreased food intake and increased energy expenditure [12, 14] . Additionally, PPARGC1A has also been shown to be critical in energy metabolism due to its increased expression in tissues with high-oxidative capacity such as muscle fibers and brown adipose tissue [15] .
Obesity continues to be a strong determinant for cardiovascular disease; however there are many methods of determining an individual's weight classification. Our data show that when characterizing by body fat percent clinical indices mirror cardiovascular risk factors more appropriately than when characterizing by BMI. When grouping according to body fat percent the cardiovascular risk factors including elevated total cholesterol, triglycerides, LDL, and serum insulin are evident. Comparatively, elevated systolic blood pressure and HDL were noted when the sample was classified based on BMI. There were clear and significant differences in the pattern of modifiable cardiovascular risk factors based on method of weight classification.
Limitations of this study include a small sample size and additionally, the effects of ethnicity were not considered. Although the overall sample controlled for gender and race, the results may be confounded by percent fat differences between the genders. Confirmation of these findings in a larger cohort is warranted.
In summary, this research showed there are differences when characterizing an individual based on BMI and body fat percent including areas of genetic expression and clinical indices. Not only might low risk individuals be inadvertently misclassified but also those at high cardiovascular risk, due to high body fat, may be missed. Therefore, using only BMI clinically and genetically may not be enough to accurately determine individual risk. Special attention should be considered when phenotyping to determine an individual's cardiovascular risk. 
